Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

References

• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362(9399)1907–17
   PubMed Web of Science ®Google Scholar
• Poston GJ. Surgical strategies for colorectal liver metastases. Surg Oncol 2004; 13: 125–36
   PubMed Web of Science ®Google Scholar
• Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225–35
   PubMed Web of Science ®Google Scholar
• Verhoef C, Visser O, de Man RA, de Wilt JH, IJzermans JN, Janssen ML. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. Eur J Cancer 2004; 40: 1530–8
   PubMedGoogle Scholar
• Yoon SS, Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist 1999; 4: 197–208
   PubMedGoogle Scholar
• Llovet JM, Beaugrand M. Hepatocellular carcinoma: Present status and future prospects. J Hepatol 2003; 38(Suppl 1)S136–S149
   PubMedGoogle Scholar
• Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: Systematic review. Lancet Oncol 2004; 5: 550–60
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–70
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Göranson H, Kraepelien T. Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurgery 1998; 1: 63–74
   Google Scholar
• Dawson LA, McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210–8
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Larson D, Naslund I. Extracranial stereotactic radiosurgery of localized targets. J Radiosurgery 1998; 1: 135–48
   Google Scholar
• Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677–83
   PubMed Web of Science ®Google Scholar
• Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177: 645–55
   PubMed Web of Science ®Google Scholar
• Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002; 53: 810–21
   PubMed Web of Science ®Google Scholar
• Cheng JC, Wu JK, Lee PC, Liu HS, Jian JJ, Lin YM, et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2004; 60: 1502–9
   PubMedGoogle Scholar
• Jiang GL, Liang SX, Zhu XD, Fu XL, Lu HF. Radiation-induced liver disease in three-dimensional conformal radiotherapy for primary liver carcinoma. Abstract. Int J Radiat Oncol Biol Phys 2004; 60(Suppl 1)413
   Google Scholar
• Fuss M, Thomas CR, Jr. Stereotactic body radiation therapy: An ablative treatment option for primary and secondary liver tumors. Ann Surg Oncol 2004; 11: 130–8
   PubMed Web of Science ®Google Scholar
• Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, et al. Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 2001; 19: 164–70
   PubMed Web of Science ®Google Scholar
• Schefter T, Gaspar LE, Kavanagh BD, Ceronsky N, Feiner A, Stuhr K. Hypofractionated extracranial stereotactic radiotherapy for liver tumors. Abstract. Int J Radiat Oncol Biol Phys. 2003; 57(Suppl 1)S282
   PubMedGoogle Scholar
• Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004; 58: 1114–20
   PubMedGoogle Scholar
• Herfarth KK, Debus J. Stereotactic radiation therapy for liver metastases. Chirurg 2005; 76: 564–9
   PubMedGoogle Scholar
• Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 150–5
   PubMed Web of Science ®Google Scholar
• Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1371–8
   PubMed Web of Science ®Google Scholar